OLIVIA WILKINS: Open Payments
NPI 1487278230 · BOONE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$6,141 in 126 payments from 17 companies in 2025. Trend: 2023 $1,310 · 2024 $1,583 · 2025 $6,141
Consulting: $2,970Food & beverage: $2,682Travel & lodging: $473Education: $16
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 19 | $3,899 |
| ABBVIE INC. | 20 | $444 |
| PFIZER INC. | 24 | $425 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $222 |
| Lilly USA, LLC | 10 | $184 |
| Janssen Biotech, Inc. | 6 | $178 |
| Aimmune Therapeutics, Inc. | 8 | $151 |
| Ardelyx, Inc. | 5 | $108 |
| Novo Nordisk Inc | 4 | $106 |
| Regeneron Healthcare Solutions, Inc. | 4 | $98 |
Products named: XELJANZ, OMVOH, DUPIXENT, TREMFYA, VELSIPITY, REZDIFFRA, ZENPEP, RINVOQ.
Industry payments across NC — which companies pay providers there.
